| 4th ESO–ESMO international consensus guidelines for advanced breast cancer (ABC 4) F Cardoso, E Senkus, A Costa, E Papadopoulos, M Aapro, F André, ... Annals of Oncology 29 (8), 1634-1657, 2018 | 1242 | 2018 |
| 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5) F Cardoso, S Paluch-Shimon, E Senkus, G Curigliano, MS Aapro, F André, ... Annals of Oncology 31 (12), 1623-1649, 2020 | 1068 | 2020 |
| Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial D Tripathy, SA Im, M Colleoni, F Franke, A Bardia, N Harbeck, SA Hurvitz, ... The lancet oncology 19 (7), 904-915, 2018 | 920 | 2018 |
| 3rd ESO–ESMO international consensus guidelines for advanced breast cancer (ABC 3) F Cardoso, A Costa, E Senkus, M Aapro, F André, CH Barrios, J Bergh, ... The Breast 31, 244-259, 2017 | 898 | 2017 |
| ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2) F Cardoso, A Costa, L Norton, E Senkus, M Aapro, F Andre, CH Barrios, ... The Breast 23 (5), 489-502, 2014 | 851 | 2014 |
| Epidemiology and prognosis of breast cancer in young women HA Assi, KE Khoury, H Dbouk, LE Khalil, TH Mouhieddine, NS El Saghir Journal of thoracic disease 5 (Suppl 1), S2, 2013 | 511 | 2013 |
| Trends in epidemiology and management of breast cancer in developing Arab countries: a literature and registry analysis NS El Saghir, MK Khalil, T Eid, AR El Kinge, M Charafeddine, F Geara, ... International journal of surgery 5 (4), 225-233, 2007 | 450 | 2007 |
| 1st International consensus guidelines for advanced breast cancer (ABC 1) F Cardoso, A Costa, L Norton, D Cameron, T Cufer, L Fallowfield, ... The Breast 21 (3), 242-252, 2012 | 416 | 2012 |
| Optimisation of breast cancer management in low-resource and middle-resource countries: executive summary of the Breast Health Global Initiative consensus, 2010 BO Anderson, E Cazap, NS El Saghir, CH Yip, HM Khaled, IV Otero, ... The lancet oncology 12 (4), 387-398, 2011 | 385 | 2011 |
| Effects of young age at presentation on survival in breast cancer NS El Saghir, M Seoud, MK Khalil, M Charafeddine, ZK Salem, FB Geara, ... BMC cancer 6, 1-8, 2006 | 385 | 2006 |
| Overview, prevention and management of chemotherapy extravasation FY Kreidieh, HA Moukadem, NS El Saghir World journal of clinical oncology 7 (1), 87, 2016 | 239 | 2016 |
| Tumor boards: optimizing the structure and improving efficiency of multidisciplinary management of patients with cancer worldwide NS El Saghir, NL Keating, RW Carlson, KE Khoury, L Fallowfield American Society of Clinical Oncology Educational Book 34 (1), e461-e466, 2014 | 228 | 2014 |
| Cancer epidemiology and control in the arab world-past, present and future EI Salim, MA Moore, JA Al-Lawati, J Al-Sayyad, A Bazawir, A Bener, ... Asian Pac J Cancer Prev 10 (1), 3-16, 2009 | 219 | 2009 |
| Breast cancer management in low resource countries (LRCs): consensus statement from the Breast Health Global Initiative NS El Saghir, CA Adebamowo, BO Anderson, RW Carlson, PA Bird, ... The Breast 20, S3-S11, 2011 | 218 | 2011 |
| Enhancing global access to cancer medicines J Cortes, JM Perez‐García, A Llombart‐Cussac, G Curigliano, ... CA: a cancer journal for clinicians 70 (2), 105-124, 2020 | 175 | 2020 |
| Breast cancer treatment: A phased approach to implementation M Mutebi, BO Anderson, C Duggan, C Adebamowo, G Agarwal, Z Ali, ... Cancer 126, 2365-2378, 2020 | 152 | 2020 |
| Supportive care after curative treatment for breast cancer (survivorship care): resource allocations in low-and middle-income countries. A Breast Health Global Initiative 2013 … PA Ganz, CH Yip, JR Gralow, SR Distelhorst, KS Albain, BL Andersen, ... The Breast 22 (5), 606-615, 2013 | 152 | 2013 |
| Updated Overall Survival of Ribociclib plus Endocrine Therapy versus Endocrine Therapy Alone in Pre- and Perimenopausal Patients with HR+/HER2− Advanced … YS Lu, SA Im, M Colleoni, F Franke, A Bardia, F Cardoso, N Harbeck, ... Clinical Cancer Research 28 (5), 851-859, 2022 | 135 | 2022 |
| ESMO/ASCO recommendations for a global curriculum in medical oncology edition 2016 C Dittrich, M Kosty, S Jezdic, D Pyle, R Berardi, J Bergh, N El-Saghir, ... ESMO open 1 (5), e000097, 2016 | 135 | 2016 |
| Angiogenesis and cancer: a cross-talk between basic science and clinical trials (the “do ut des” paradigm) G de Castro Junior, F Puglisi, E de Azambuja, NS El Saghir, A Awada Critical reviews in oncology/hematology 59 (1), 40-50, 2006 | 126 | 2006 |
Ali ShamseddineProfessor of Hematology-Oncology, American University of Beirut Medical Center在 aub.edu.lb 的电子邮件经过验证
